Cancer Clinical Trials in the Era of Personalized Medicine – Keynote Session at CHI Event

PRLog (Press Release) - Dec. 8, 2011 - Cambridge Healthtech Institute announces the keynote session to be held at its second annual Oncology Clinical Trials: Bringing Targeted & Tailored Cancer Therapy to Patient conference to be held on February 21-23, 2012 at the Moscone North Convention Center in San Francisco, CA.

Presentations include:

Cancer Clinical Trials in the Era of Personalized Medicine: a Sponsor's Perspective
Hal Barron, M.D., Executive Vice President, CMO, Global Product Development, Roche Holding AG

Methodologic Issues in Clinical Trials in the Era of Personalized Therapy
Margaret A. Tempero, M.D., Doris and Donald Fisher Distinguished Professorship, Professor of Medicine, Division of Hematology and Oncology; Director of Research Programs; Deputy Director, UCSF Helen Diller Family Comprehensive Cancer Center

Cancer Clinical Trials in the Era of Personalized Medicine: An Investigator's Perspective
Steven Piantadosi, M.D., Ph.D., Chair & Director, Phase One Foundation, Samuel Oschin Comprehensive Cancer Institute

Advance registration discounts are available until January 13, 2012. To view more presentations and speaker abstracts and to register, please visit http://www.TriConference.com/cct

To inquire about sponsoring and/or exhibiting, contact Jon Stroup, 781-972-5483, jstroup@healthtech.com.

Writers and editors are encouraged to attend. To request a press pass, contact Tracey Fielding at tfielding@healthtech.com.

About Cambridge Healthtech Institute (www.chicorporate.com)

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com